Dr. George Miller is a surgical oncologist with Trinity Health of New England where he specializes in cancers of the liver, pancreas, and GI tract. He was born and raised in Brooklyn, NY and was educated at Columbia College where he graduated summa cum laude, Phi Beta Kappa and received his MD from McGill University Faculty of Medicine. He completed his residency training in General Surgery at NYU and a trio of fellowships at Memorial Sloan Kettering Cancer Center in Surgical Oncology, Hepatobiliary-Pancreatic Surgery, and Experimental Immunology.

Dr. Miller was on the faculty of NYU School of Medicine for 13 years where he was the inaugural HL Pachter Professor of Surgery and Cell Biology and principal investigator of one of the world’s most productive cancer research laboratories. His lab was awarded ~20 grants from the NIH and Department of Defense and more than 70 grants in total. He is the recipient of prestigious awards from organizations such as the Society of University Surgeons, the American Liver Foundation, and the American Association for Cancer Research (AACR) and in 2017 was awarded the Ruth Leff Siegel Award given annually to scientist making the most important contribution to pancreas cancer research.

He has been the keynote speaker at AACR and other prominent national meetings. His research has been published in leading journals including multiple papers in Nature, Cancer Discovery, Nature Medicine, and Cell and his work has been translated to 4 Phase I clinical trials. He has also partnered with industry to develop 5 new cancer therapeutics that have entered clinical testing and has co-founded a successful start-up company focusing on the development of novel immune-based therapies. His seminal work includes contributions to the roles of the microbiome, innate immunity, and inflammatory cell death in oncogenesis.

Dr. Miller was the leader of NYU’s 35-member Tumor Immunology Program, co-leader of NYU’s GI Disease Management Group, and director of the nation’s only T32 NCI Training grant in Gastrointestinal Oncology. Dr. Miller was awarded the 2018 Mentor of the Year Award from NYU School of Medicine and was twice nominated for university-wide medal of excellence for teaching. He currently serves as Editor-in-Chief of Oncogene. Dr. Miller is a member of the American Surgical Association and the American Society for Clinical Investigation. He sees patients with liver cancer, pancreas cancer, and stomach cancer and has performed more than 300 major liver resections and 200 pancreatectomies.